NEWMarkets

Abbott Labs (ABT) stock price target cut to $120 by Benchmark

Published on 4/17/2026

#ABT#Benchmark#stock target#valuation
Abbott Labs (ABT) stock price target cut to $120 by Benchmark

AI Summary

Benchmark has reduced its price target for Abbott Labs (ABT) stock to $120. This change reflects a re-evaluation of the company's valuation metrics. Such a downgrade can influence market perceptions and potentially impact stock performance. It is essential to monitor how this adjustment affects trading volume and investor sentiment moving forward.

Source: Read original article (opens in new tab)

Related News

U.S. Stock Futures Rise on Trump Iran Comments; Dow Up 240 Points
Markets

U.S. Stock Futures Rise on Trump Iran Comments; Dow Up 240 Points

Apr 17

S&P 500 Tops 7000 Amid Positive Corporate Earnings Signals
Markets

S&P 500 Tops 7000 Amid Positive Corporate Earnings Signals

Apr 17

Goldman Reports South Korean Stocks Undervalued Despite Rebound
Markets

Goldman Reports South Korean Stocks Undervalued Despite Rebound

Apr 17

Stocks Making Big Moves: Netflix, Oracle, Affirm and More
Markets

Stocks Making Big Moves: Netflix, Oracle, Affirm and More

Apr 17